Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 5:12:687-695.
doi: 10.2147/HIV.S261420. eCollection 2020.

Alarm Clock-Based Reminder for Improving Low Adherence on Option B Plus Antiretroviral Therapy Among HIV Positive Pregnant and Lactating Mothers in Northern Ethiopia

Gebremedhin Gebreegziabher Gebretsadik  1 , Hailay Gebretnsae  2 , Mulu Ftwi  1 , Afewerki Tesfahunegn  3
Affiliations

Alarm Clock-Based Reminder for Improving Low Adherence on Option B Plus Antiretroviral Therapy Among HIV Positive Pregnant and Lactating Mothers in Northern Ethiopia

Gebremedhin Gebreegziabher Gebretsadik et al. HIV AIDS (Auckl). .

Abstract

Background: Option B plus antiretroviral therapy (ART) is an approach used to eliminate new Human Immune Deficiency Virus (HIV) infections among infants. Considering the high adherence on Option B plus ART in HIV positive mothers is a crucial part in preventing mother-to-child transmission HIV. Therefore, this study was performed to assess the status of adherence and factors related to Option B plus ART.

Methods: A cross-sectional study design was conducted in Eastern zone of Tigrai Region from January to February 2017. Data were collected by using pre-tested structured interviewer-administered questionnaire from 350 participants selected using simple random sampling. Descriptive and binary logistic regression was done during analysis.

Results: The overall good adherence status of Option B plus ART among pregnant and lactating mothers was 67.3% [62.3-72.3%]. Attending formal education (AOR=2.78, 95% CI 1.52-5.07), traveling for <1 hour to reach health facility (AOR=2.03, 95% CI 1.19-3.44), (CD4) count <350 cells/mm3 (AOR=2.3, 95% CI 1.33-3.95), starting their Option B plus during pregnancy (AOR= 2.08, 95% CI 1.08-3.97), taking one pill per day (AOR=2.12, 95% CI 1.25-3.58), using a clock as a reminder (AOR=2.51, 95% CI 1.3-4.86), and having good male involvement (AOR=2.91, 95% CI 1.64-5.16) were associated with good level of adherence for Option B plus ART treatment.

Conclusion: Our study revealed that the level of good adherence is low compared with the national target. Therefore, addressing the low adherence of Option B plus ART requires a policy response, such as efforts to enhance male partner involvement and better service accessibility in Prevention of Mother-to-Child Transmission (PMTCT) program. Moreover, health care providers and policymakers need to maximaze their efforts on HIV positive pregnant and lactating mothers using a clock as a reminder.

Keywords: Ethiopia; Option B plus ART; Prevention of Mother-to-Child Transmission program; PMTCT; adherence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests for this work.

Figures

Figure 1
Figure 1
Reasons for not taking Option B plus ART in eastern zone of Tigrai, Ethiopia, 2017 (N= 115).
See this image and copyright information in PMC

References

    1. World Health Organization. The Strategic Use of Antiretrovirals for Treatment and Prevention of HIV Infection: Report of a WHO Technical Consultation. Geneva: Switzerland; November 14–16, 2011.
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS, World Health Organization WHO). AIDS Epidemic Update, 2009. UNAIDS; 2009.
    1. Demographic E. Health Survey 2011 Central Statistical Agency Addis Ababa. Maryland, USA: Ethiopia ICF International Calverton; 2012.
    1. Besada D, Van Cutsem G, Goemaere E, Ford N, Bygrave H, Lynch S. The case for option B and optional B+: ensuring that South Africa’s commitment to eliminating mother-to-child transmission of HIV becomes a reality. South Afr J HIV Med. 2012;13(4):178–181. doi:10.4102/sajhivmed.v13i4.112 - DOI
    1. World Health Organization.Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach-2010 version. World Health Organization; 2010. - PubMed

LinkOut - more resources